Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROTIGOTINE Cause Stent placement? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Stent placement have been filed in association with ROTIGOTINE (Neupro). This represents 0.1% of all adverse event reports for ROTIGOTINE.

5
Reports of Stent placement with ROTIGOTINE
0.1%
of all ROTIGOTINE reports
0
Deaths
3
Hospitalizations

How Dangerous Is Stent placement From ROTIGOTINE?

Of the 5 reports, 3 (60.0%) required hospitalization.

Is Stent placement Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROTIGOTINE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ROTIGOTINE Cause?

Product adhesion issue (1,718) Off label use (646) Drug ineffective (632) Death (595) Parkinson's disease (419) Fall (412) Device adhesion issue (383) Overdose (353) Application site pruritus (334) Application site erythema (330)

What Other Drugs Cause Stent placement?

RANOLAZINE (593) EVOLOCUMAB (244) ADALIMUMAB (227) ROSIGLITAZONE (196) ETANERCEPT (174) CLOPIDOGREL BISULFATE (167) RIVAROXABAN (122) ASPIRIN (118) APIXABAN (116) MACITENTAN (108)

Which ROTIGOTINE Alternatives Have Lower Stent placement Risk?

ROTIGOTINE vs ROXADUSTAT ROTIGOTINE vs ROXICODONE ROTIGOTINE vs ROXITHROMYCIN ROTIGOTINE vs ROZANOLIXIZUMAB ROTIGOTINE vs ROZANOLIXIZUMAB-NOLI

Related Pages

ROTIGOTINE Full Profile All Stent placement Reports All Drugs Causing Stent placement ROTIGOTINE Demographics